SLC5A2 and chronic kidney disease: Furthermore, a prospective observational study of patients aged ≥75 years hospitalized for acute decompensated heart failure with stage 3-4 CKD found that SGLT2 inhibitors were associated with slower eGFR decline than loop diuretics.55